Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LY3143921 |
Synonyms | |
Therapy Description |
LY3143921 is an ATP-competitive CDC7 inhibitor that inhibits cell-cycle progression, which may lead to anti-tumor activity (J Clin Oncol 37, 2019 (suppl; abstr TPS3167)). |